Pfizer has said its maternal vaccine couldpreventup to 16,000 hospitalizations and more than 300,000 visits to the doctor due to RSV if the shot becomes available in the U.S. this fall and winter. "This fall marks the start of the annual respiratory infection season in the Northern Hem...
For COVID-19, coverage is even worse: Just 17% of adults aged 18 and up and about 8% of children have gotten the latest shot, according to CDC data. That includes about 36% of seniors, who are at higher risk forsevere disease. Even the new RSVvaccineisn't being embraced byolder ad...
Pfizer and Moderna. To that end, GSK used a priority review voucher to speed its age extension application through the FDA approval process. The agency is currently reviewing an application from Pfizer to extend the license for its RSV vaccine, Abrysvo,...
Beyfortus is a one-dose injected drug made of monoclonal antibodies, which are proteins manufactured in a lab that mimic antibodies the body naturally creates when fighting an infection. Though given as an intramuscular injection, Beyfortus works in a different mechanism than a v...
“The data we will publish today and next week demonstrate the vaccine effectiveness against SARS CoV-2 infection is waning,” CDC DirectorRochelle Walenskysaid during a press briefing. “And even though our vaccines are currently working well to prevent hospitalizations, we are seeing concer...
Thompson, Dennis
GSK's vaccine, called Arexvy, and Pfizer's vaccine, called Abrysvo, target a protein from the virus called the F protein that RSV uses to attach to human cells and infect people. The vaccine stimulates antibodies against the protein and protects against infection. GSK's shot...
Health officials have estimated about two cases of Guillain-Barre syndrome in every 1 million people who receive the RSV vaccine within three weeks of getting the shot. The new CDC report focused on 28 cases of the syndrome in people who were vaccinated, and all but one developed symptoms wit...
Although the CDC's vaccine advisory panel only looked at the Pfizer vaccine, the CDC "will address, with the same sense of urgency, recommendations for the Moderna and J&J vaccines as soon as those data are available," Walensky noted. ...
The vote to recommend the vaccine was 11 to 1. The specific question advisers voted on was: “Maternal RSV vaccine is recommended for pregnant people during 32 through 36 weeks gestation, using seasonal administration, to prevent RSV lower respiratory tract infection in infants.” The vaccine, na...